Clinical Cardiac Rehabilitation Registry Study

Study Overview
=================
Brief Summary
-----------------
Establish an electronic cardiac rehabilitation patient registration system and clinical database, carry out prospective cohort follow-up and observation of cardiovascular disease (CVD) patients receiving cardiac rehabilitation in inpatients and outpatients, collect risk factors, diagnosis and treatment status, rehabilitation diagnosis and treatment, clinical outcomes and follow-up results, and establish a short-term and long-term follow-up mechanism.

Detailed Description
-----------------
Establish an electronic cardiac rehabilitation patient registration system and clinical database, carry out prospective cohort follow-up and observation of cardiovascular disease (CVD) patients receiving cardiac rehabilitation in inpatients and outpatients, collect risk factors, diagnosis and treatment status, rehabilitation diagnosis and treatment, clinical outcomes and follow-up results, and establish a short-term and long-term follow-up mechanism. Through the real world clinical practice data of cardiac rehabilitation of CVD patients, describe the population and disease characteristics of cardiac rehabilitation patients, the provision of cardiac rehabilitation services and the influencing factors; Analyze and study the key technologies of clinical cardiac rehabilitation, evaluate the implementation quality of cardiac rehabilitation, improve the clinical pathway of cardiac rehabilitation, and optimize the service process.

Official Title
-----------------
Clinical Cardiac Rehabilitation Registry Study

Conditions
-----------------
Cardiac Rehabilitation

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: 18 years of age and older. Patients receiving inpatient cardiac rehabilitation, and/or participating in outpatient cardiac rehabilitation. All cases selected were in New York Heart Association (NYHA) cardiac function class II and below. Normal troponin. Patients with some ability to communicate and understand. have signed an informed consent form. - Exclusion Criteria: Subjects who are participating in clinical trials of other drugs or devices. Patients with NYHA cardiac function class III or higher. Mentally impaired, or unable to communicate effectively with investigators. Refusal to sign the informed consent form.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| All-cause and attributed deaths | All-cause and attributed deaths during hospitalization and follow-up of CVD patients | 1-year and 2-year | 
| Major adverse cardiovascular events (MACE) occurrence | Major adverse cardiovascular events (MACE) occurrence include cardiovascular death, non-fatal stroke, non-fatal myocardial infarction (MI), and ischemia-driven revascularization. | 1-year and 2-year | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Cardiopulmonary function and quality of life | Cardiopulmonary function and quality of life in cardiac rehabilitation patients during the follow-up period | 1-year and 2-year | 
| Participation and adherence | Participation and adherence in outpatient cardiac rehabilitation. | 1-year and 2-year | 
| Medical costs of cardiac rehabilitation patients during hospitalization and up to 2 years after discharge. | Medical costs of cardiac rehabilitation patients during hospitalization and up to 2 years after discharge. | 1-year and 2-year | 
| Proportion of different comorbidities, interactions and prognosis in CVD. | Proportion of different comorbidities, interactions and prognosis in CVD. | 1-year and 2-year |